Financial statements Symbiotics
Balance sheet data of SYMBIOTICS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 914 213,21 | 7 690 586,33 | 16 243 064,70 | 28 480 910,47 | 38 031 843,95 | 41 983 807,04 |
| A. Fixed assets | 0,00 | 0,00 | 847 841,04 | 5 752 192,42 | 7 064 712,24 | 8 786 989,23 |
| B. Current assets | 5 914 213,21 | 7 690 586,33 | 15 395 223,66 | 22 728 718,05 | 30 967 131,71 | 33 196 817,81 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 5 914 213,21 | 7 690 586,33 | 16 243 064,70 | 28 480 910,47 | 38 031 843,95 | 41 983 807,04 |
| A. Equity | 1 292 423,19 | 5 397 375,90 | 14 395 609,64 | 24 770 133,31 | 35 394 179,64 | 38 561 038,92 |
| B. Liabilities and provisions for liabilities | 4 621 790,02 | 2 293 210,43 | 0,00 | 3 710 777,16 | 2 637 664,31 | 3 422 768,12 |
| I. Long-term liabilities | 142 448,52 | 146 308,87 | 0,00 | 336 585,82 | 45 817,75 | 911 675,03 |
| II. Short-term liabilities | 4 479 341,50 | 2 146 901,56 | 677 980,12 | 3 374 191,34 | 2 591 846,56 | 2 511 093,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.